Oncimmune (AgeTech UK) Medical (Diagnostic Tool)
Biomarker proprietary platform to test for cancer cell signatures, during/post therapy.
Connections from
Funding Status:
N/A
Headquarters:
United Kingdom
Founded Date:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Technology:
AgeTech Companies
Employee Number:
N/A
Number Of Exists:
N/A
Industry:
UK AgeTech 2020